Notably, PRMT2 has been implicated in the regulation of expression within HCC cells, acting through the methylation of H3R8me2a at Bcl2 (encoded by BCL2 apoptosis regulator gene) promoter, increasing Bcl2 and Stab gene expression (Fig. 3C). The gene discussed is BCL2; the disease is hepatocellular carcinoma.